APOTHEEK DEMEER
ActiveSummary
APOTHEEK DEMEER has been active since 1992 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €370,619 and a net result of €83,524. Equity has been growing by about 7.2% per year since 2019. Its solvency ranks better than 65% of 5,039 sector peers (NACE 47, financial year 2025). The computed 12-month bankruptcy probability is 0.2% (very low).
Overview
Official details
Source: KBO- Status
- Active since 17-01-1992 Normal situation
- Activity
- Retail sale of pharmaceutical products NACE 47730
- Joint committee
- 313 Paritair Comité voor de apotheken en tarificatiediensten · annual accounts 2025
- Establishment unit
- 2.056.414.054 3001 Leuven, since 02-03-1992
- Financial year end
- 31 December
- Peppol
- Reachable since 04-12-2025
Board and ownership
- Ansophar bvManaging director · permanent representative DEMEER Ann Sophie
- Sven AlaertsDirector
- ANSOPHAR100%· score 69annual accounts 2025
- Ansophar BVconsolidatesannual accounts 2025
Financial position
- Bankruptcy probabilitywithin 12 months
- 0.2%
- Gross margin
- €228,398
- ▲ 24.0%
- Turnover
- ≈ €1.1m
- estimated
- Profit
- €83,524
- ▲ 91.6%
- Equity
- €370,619
- ▲ 1.0%
- Total assets
- €740,882
- ▲ 8.6%
- Employees on 31-12-2025
- 2
- =
- 2025 accounts filed 73 days after the deadline
Score breakdownraises riskLast filed accounts filed 73 days late; 1 of the last 3 accounts lateSector: Retail trade (NACE 47)lowers riskFounded in 1992Size: 1.2 FTE, total assets €740,882Show the evidence
Checked score
About 2 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
Calculation
The band follows from the bankruptcy probability. 10 more points roughly halve it.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 47, micro). It does better than 64% of them on solvency, 40% on liquidity, 76% on profitability and 43% on growth.
The bankruptcy probability was computed on 02-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
The company filed its last 7 accounts on average 4 days after the deadline. In the sector (NACE 47), the median for financial year 2024 was on the deadline day, and 47% of those companies filed late.
Searched, nothing found (2)
Recent changes
- · Gazette deed 2 reappointedReappointments: ANSOPHAR (director) and ALAERTS Sven Ludovicus Victor (director) · Permanent representative: DEMEER Ann Sophie
- · Gazette deed 3 reappointedReappointments: Ansophar bv (director) and Sven Alaerts (director) · Permanent representative: Ann-Sophie Demeer
- · Gazette deed Incorporation
Comparable companies
These companies have the same main activity as APOTHEEK DEMEER: retail sale of pharmaceutical products (NACE 47730). They are comparable in size and age: total assets between €601,000 and €822,000, founded between 1986 and 1994.
| Company | Total assets | Gross margin |
|---|---|---|
| APOTHEEK DEMEER Leuven | €740,882 | €228,398 |
| APOTEEK VERLINDE Dentergem | €734,257 | €240,432 |
| 'T BEGIJNTJE Begijnendijk | €739,207 | €253,520 |
| APOTHEEK PEUTIE Vilvoorde | €724,942 | €267,677 |
| APOTEEK STAES Diest | €650,270 | €232,230 |
| APOTHEEK DECALUWE Linter | €821,999 | €186,983 |
| APOTHEEK DE WITTE Asse | €600,646 | €187,991 |
Key facts about APOTHEEK DEMEER
- What is the company number of APOTHEEK DEMEER?
- The company number of APOTHEEK DEMEER is 0446.367.670. The VAT number is the same number with BE in front: BE 0446.367.670.
- Where is APOTHEEK DEMEER based?
- The registered office is at Naamsesteenweg 224, 3001 Leuven.Company details
- What does APOTHEEK DEMEER do?
- According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
- What is the legal form of APOTHEEK DEMEER?
- The legal form of APOTHEEK DEMEER is Public limited company (NV).
- When was APOTHEEK DEMEER founded?
- APOTHEEK DEMEER was founded on 17-01-1992.
- Is APOTHEEK DEMEER still active?
- Yes, APOTHEEK DEMEER is an active enterprise in the KBO register.
- How many employees does APOTHEEK DEMEER have?
- APOTHEEK DEMEER had an average of 1.2 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
- Which joint committee does APOTHEEK DEMEER fall under?
- In its 2025 annual accounts, APOTHEEK DEMEER states joint committee 313 (Paritair Comité voor de apotheken en tarificatiediensten).
- What is the turnover of APOTHEEK DEMEER?
- The turnover in financial year 2025 is ≈ €1.1m. This figure is estimated from the gross margin of €228,398 and 51 comparable companies (NACE 477). It probably lies between €720,000 and €2.1m.
- Is APOTHEEK DEMEER profitable?
- In financial year 2025, APOTHEEK DEMEER made a profit of €83,524.
- Where can I find the annual accounts of APOTHEEK DEMEER?
- APOTHEEK DEMEER filed 34 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of APOTHEEK DEMEER due?
- APOTHEEK DEMEER must file the annual accounts for financial year 2026 by 31-07-2027.Timeline
Next steps
See how customers, suppliers and banks see your own company and what to improve first.